Event chart ASTRAZENECA PLC |
|
|
Upcoming events on ASTRAZENECA PLC |
|
07/29/22 | | Interim 2022 Earnings Release |
11/10/22 | | Q3 2022 Earnings Release (Projected) |
02/02/23 | | FY 2022 Earnings Release (Projected) |
04/28/23 | | Q1 2023 Earnings Release (Projected) |
07/27/23 | | Interim 2023 Earnings Release (Projected) |
|
Past events on ASTRAZENECA PLC |
|
06/23/22 | | JP Morgan European Healthcare Conference |
06/22/22 | | ODDO BHF Sustainability Forum |
06/14/22 | | Goldman Sachs Global Healthcare Conference |
06/12/22 | 05:30am | | European Hematology Association Meeting - Abstract #S267 |
06/10/22 | 10:30am | | European Hematology Association Meeting - Abstract #P834 |
06/10/22 | 10:30am | | European Hematology Association Meeting - Abstract #P813 |
06/10/22 | 10:30am | | European Hematology Association Meeting - Abstract #P812 |
06/10/22 | 10:30am | | European Hematology Association Meeting - Abstract #P1129 |
06/10/22 | 10:30am | | European Hematology Association Meeting - Abstract #P1130 |
06/10/22 | 10:30am | | European Hematology Association Meeting - Abstract #P1131 |
|
Past dividends on ASTRAZENECA PLC |
|
02/24/22 | | Final Payment 1.453 GBP |
08/12/21 | | Interim Payment 0.648 GBP |
02/25/21 | | Final Payment 1.374 GBP |
08/13/20 | | Interim Payment 0.696 GBP |
02/27/20 | | Final Payment 1.464 GBP |
08/08/19 | | Interim Payment 0.719 GBP |
02/28/19 | | Final Payment 1.468 GBP |
08/09/18 | | Interim Payment 0.684 GBP |
02/15/18 | | Final Payment 1.336 GBP |
08/10/17 | | Interim Payment 0.689 GBP |
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 22 465 22 117 1,6% | 22 090 22 157 -0,30% | 24 384 24 440 -0,23% | 26 617 26 378 0,91% | 37 417 36 239 3,2% | 43 717 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 6 713 6 604 1,7% | 7 140 6 767 5,5% | 6 686 6 882 -2,8% | 8 311 8 087 2,8% | 7 586 10 816 -30% | 14 515 |
Operating profit (EBIT) M $ |
Released Forecast Spread | 6 855 6 450 6,3% | 5 672 5 897 -3,8% | 6 436 6 631 -2,9% | 7 340 7 417 -1,0% | 9 928 10 003 -0,75% | 13 636 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 2 227 2 602 -14% | 1 993 2 712 -27% | 1 548 2 081 -26% | 3 916 4 387 -11% | -265 1 510 -118% | 5 360 |
Net income M $ |
Released Forecast Spread | 3 001 2 477 21% | 2 155 2 306 -6,6% | 1 335 1 895 -30% | 3 196 2 930 9,1% | 112 2 055 -95% | 4 956 |
EPS $ |
Released Forecast Spread | 2,37 1,90 25% | 1,70 1,79 -4,8% | 1,03 1,41 -27% | 2,44 2,50 -2,3% | 0,08 1,99 -96% | 3,24 | Announcement Date | 02/02/2018 | 02/14/2019 | 02/14/2020 | 02/11/2021 | 02/10/2022 | - |
|
|
Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
Sales M $ |
Released Forecast Spread | 6 354 5 948 6,8% | 6 275 6 279 -0,07% | 6 578 6 642 -0,96% | 7 410 7 104 4,3% | 7 320 6 997 4,6% | 8 220 7 450 10% | 9 866 9 580 3,0% | 12 011 11 061 8,6% | 11 390 10 967 3,9% | 10 533 | 10 582 | 11 105 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 2 061
| 1 994
| 1 972 2 335 -16% | 2 284 1 737 31% | 2 692 2 904 -7,3% | 1 880 2 171 -13% | 1 114 3 056 -64% | 1 900 4 512 -58% | 2 187 3 894 -44% | 5 464 | 2 581 | 3 286 |
Operating profit (EBIT) M $ |
Released Forecast Spread | 1 854 1 688 9,9% | 1 792 1 679 6,7% | 1 795 1 811 -0,86% | 1 899 1 962 -3,2% | 2 524 2 545 -0,81% | 1 805 1 763 2,4% | 2 281 2 674 -15% | 3 318 3 291 0,82% | 3 961 3 486 14% | 3 291 | 3 570 | 3 169 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 935 896 4,4% | 961 761 26% | 853 910 -6,2% | 1 167 1 033 13% | 1 608 1 591 1,1% | 764 705 8,3% | -2 001 1 485 -235% | -636 1 321 -148% | 553 972 -43% | 742 | 1 332 | 1 529 |
Net income M $ |
Released Forecast Spread | 780 698 12% | 756 630 20% | 648 753 -14% | 1 012 881 15% | 1 561 1 347 16% | 550 482 14% | -1 652 1 269 -230% | -347 908 -138% | 386 1 086 -64% | 1 227 | 1 481 | 2 318 |
EPS $ |
Released Forecast Spread | 0,59 0,50 19% | 0,58 0,48 21% | 0,49 0,56 -13% | 0,78 0,67 16% | 1,19 1,02 17% | 0,42 0,37 14% | -1,10 0,85 -230% | -0,22 0,62 -135% | 0,25 0,70 -64% | 0,61 | 0,91 | 1,37 | Announcement Date | 04/29/2020 | 07/30/2020 | 11/05/2020 | 02/11/2021 | 04/30/2021 | 07/29/2021 | 11/12/2021 | 02/10/2022 | 04/29/2022 | - | - | - | |
|
|
Upcoming sector events for ASTRAZENECA PLC |
|
|
|
Past sector events for ASTRAZENECA PLC |
|
|
|
|
|
|
Pharmaceutical companies still have the upper hand |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|